HK1207861A1
(en )
2016-02-12
Substituted cycloalkenopyrazoles as bub1 inhibitors for the treatment of cancer bub1
DK2818482T3
(da )
2019-07-15
Farmaceutisk sammensætning til behandling af cancer
DK2824114T3
(da )
2019-07-29
Farmaceutisk sammensætning til behandling af cancer
DK3181128T3
(da )
2023-06-06
Farmaceutisk nilotinib-sammensætning
DK2818481T3
(da )
2019-10-14
Farmaceutisk sammensætning til behandling og/eller forebyggelse af cancer
SG2014008304A
(en )
2014-06-27
C10rf32 antibodies, and uses thereof for treatment of cancer
CL2014003165A1
(es )
2015-03-20
Proceso mejorado para la preparación de treprostinil y derivados del mismo.
HK1211979A1
(en )
2016-06-03
Pharmaceutical composition comprising albumin-binding arginine deiminase for cancer targeting treatment
DK2897594T3
(da )
2020-06-29
Farmaceutisk sammensætning
HK1222548A1
(zh )
2017-07-07
治療惡性腫瘤的藥物組合
CL2014003283A1
(es )
2016-04-01
Formulación farmacéutica.
HK1215794A1
(zh )
2016-09-15
用於治療疾病的同種異體自噬體富集組合物
HK1210710A1
(en )
2016-05-06
Pharmaceutical composition comprising rebamipide
EP2823825A4
(en )
2015-10-14
PHARMACEUTICAL COMPOSITION FOR TREATING CANCER
DK2802351T3
(da )
2019-05-13
Midler til behandling af triple-negativ brystkræft
EP3020399A4
(en )
2016-12-28
PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF CANCER
BR112013030930A2
(pt )
2017-08-08
composições farmacêuticas combinadas para o tratamento de tumores
IL233323B
(en )
2018-11-29
Medical preparations for the treatment of tumors expressing egfr and gm3 n-glycolyl ganglioside (neugcgm3)
TH1401003675A
(th )
2016-09-16
องค์ประกอบทางเภสัชกรรมสำหรับการรักษาเนื้องอกที่แสดง EGFR และ แกงกลิโอไซด์ N-ไกลโคลิล GM3 (NeuGcGM3)
ZA201502571B
(en )
2019-03-27
Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
EP2902027A4
(en )
2016-06-22
ACTIVE COMPOSITION FOR THE TREATMENT OF TUMORS AND THE USE THEREOF
HUP1200552A2
(en )
2014-04-28
Pharmaceutical compositions for the treatment of high blood pressure
ZA201305014B
(en )
2014-05-28
Method for the formation and analysis of sulfited-tetrameric,-trimeric,-dimeric and -monomeric compounds from commercial proanthocyanidins, and the use of said sulfited compounds in pharmaceutical applications
AU2013904239A0
(en )
2013-11-21
Pharmaceutical combinations for the treatment of cancer
IL232339A0
(en )
2014-06-30
32rf10c antibodies, and their uses for cancer treatment